BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Proteologics Inc.

Headquarters: Orangeburg, NY, United States of America
Year Founded: 1999
Status: Archived
Industry Sector: ProcessIndustries
CEO: Moshe Koren
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -22.74
Exchange/Ticker 1: Tel Aviv:PRTL
Exchange/Ticker 2: N/A
Latest Market Cap: $31,766,046

Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and Financing Modules.

BioCentury | May 20, 2024
Deals

Deals Report: J&J acquires Proteologix, Fog-ARTbio to develop radiotherapies 

Plus: Erasca strikes two deals for RAS-targeting therapies, AZ plans new ADC manufacturing site, and more 
BioCentury | Jan 7, 2013
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Jan 7, 2013
Company News

Teva, Proteologics deal

BioCentury | Dec 10, 2012
Company News

Proteologics board of directors update

BioCentury | Dec 3, 2012
Company News

Proteologics, Teva, XTL deal

BioCentury | Jul 21, 2011
Targets & Mechanisms

Celgene skips SKP2

BioCentury | Sep 22, 2008
Company News

Proteologics, Teva deal

BioCentury | Dec 4, 2006
Company News

Proteologics, Teva deal

Items per page:
1 - 10 of 10
Help Center
Username
Request Training
Submit Data Correction
Ask a Question